Kure Cells, INC
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Safety of UF-KURE-BCMA CAR T-Cells in Advanced Myeloma (NCT07611149) | Kure Cells, INC | 2026-09-01 |
| A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas (NCT07713459) | Kure Cells, INC | 2026-08-31 |
Track Kure Cells, INC automatically
Every clearance here is in the API, with alerts when new ones post.